CN112107612B - Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof - Google Patents
Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN112107612B CN112107612B CN202011111015.7A CN202011111015A CN112107612B CN 112107612 B CN112107612 B CN 112107612B CN 202011111015 A CN202011111015 A CN 202011111015A CN 112107612 B CN112107612 B CN 112107612B
- Authority
- CN
- China
- Prior art keywords
- parts
- group
- sample
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 210000004369 blood Anatomy 0.000 title claims abstract description 50
- 239000008280 blood Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 230000003796 beauty Effects 0.000 title claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 80
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 47
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 47
- 235000008434 ginseng Nutrition 0.000 claims abstract description 47
- 241000287828 Gallus gallus Species 0.000 claims abstract description 25
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 24
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 235000006533 astragalus Nutrition 0.000 claims abstract description 18
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- 239000000843 powder Substances 0.000 claims description 51
- 108010010803 Gelatin Proteins 0.000 claims description 45
- 229920000159 gelatin Polymers 0.000 claims description 45
- 239000008273 gelatin Substances 0.000 claims description 45
- 235000019322 gelatine Nutrition 0.000 claims description 45
- 235000011852 gelatine desserts Nutrition 0.000 claims description 45
- 238000003756 stirring Methods 0.000 claims description 40
- 241001465754 Metazoa Species 0.000 claims description 37
- 241000196324 Embryophyta Species 0.000 claims description 29
- 239000000706 filtrate Substances 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 244000197580 Poria cocos Species 0.000 claims description 16
- 235000008599 Poria cocos Nutrition 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 16
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 15
- 235000017803 cinnamon Nutrition 0.000 claims description 15
- 241000005787 Cistanche Species 0.000 claims description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 14
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 14
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 14
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 13
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 13
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 13
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 13
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 13
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 13
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 13
- 240000000171 Crataegus monogyna Species 0.000 claims description 13
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 13
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 13
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 13
- 244000241838 Lycium barbarum Species 0.000 claims description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims description 13
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 13
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 13
- 240000007651 Rubus glaucus Species 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 238000005325 percolation Methods 0.000 claims description 12
- 235000008708 Morus alba Nutrition 0.000 claims description 11
- 240000000249 Morus alba Species 0.000 claims description 10
- 238000011049 filling Methods 0.000 claims description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 8
- 240000002943 Elettaria cardamomum Species 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 235000005300 cardamomo Nutrition 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims description 8
- 239000004302 potassium sorbate Substances 0.000 claims description 8
- 229940069338 potassium sorbate Drugs 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 8
- 238000007670 refining Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 6
- -1 oral solution Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- 239000005995 Aluminium silicate Substances 0.000 claims description 4
- 241001061264 Astragalus Species 0.000 claims description 4
- 235000012211 aluminium silicate Nutrition 0.000 claims description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 230000001502 supplementing effect Effects 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 235000020429 malt syrup Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 235000013330 chicken meat Nutrition 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 56
- 230000007958 sleep Effects 0.000 abstract description 19
- 235000013305 food Nutrition 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 169
- 241000699670 Mus sp. Species 0.000 description 51
- 240000004371 Panax ginseng Species 0.000 description 41
- 230000000052 comparative effect Effects 0.000 description 35
- 239000000243 solution Substances 0.000 description 28
- 241000699666 Mus <mouse, genus> Species 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 20
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 18
- 239000013641 positive control Substances 0.000 description 18
- 230000032683 aging Effects 0.000 description 16
- 102000019197 Superoxide Dismutase Human genes 0.000 description 15
- 108010012715 Superoxide dismutase Proteins 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 13
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 229940118019 malondialdehyde Drugs 0.000 description 12
- 229960001412 pentobarbital Drugs 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 230000009182 swimming Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 102000000588 Interleukin-2 Human genes 0.000 description 8
- 108010002350 Interleukin-2 Proteins 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 8
- 210000001772 blood platelet Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 230000004620 sleep latency Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 102000003951 Erythropoietin Human genes 0.000 description 7
- 108090000394 Erythropoietin Proteins 0.000 description 7
- 102000000646 Interleukin-3 Human genes 0.000 description 7
- 108010002386 Interleukin-3 Proteins 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 229930013930 alkaloid Natural products 0.000 description 7
- 235000019606 astringent taste Nutrition 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 229940105423 erythropoietin Drugs 0.000 description 7
- 229940076264 interleukin-3 Drugs 0.000 description 7
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 7
- 230000004622 sleep time Effects 0.000 description 7
- 235000020357 syrup Nutrition 0.000 description 7
- 239000006188 syrup Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000009759 skin aging Effects 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- 230000037308 hair color Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 241000628997 Flos Species 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 108010052008 colla corii asini Proteins 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229960002275 pentobarbital sodium Drugs 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000006944 antioxidant bioactivity Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000009975 flexible effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 230000000640 hydroxylating effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000003582 thrombocytopenic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The application discloses a traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young and a preparation method and application thereof, wherein the traditional Chinese medicine composition comprises the following raw materials in parts by weight: 125-145 parts of chicken embryo, 1-10 parts of astragalus membranaceus, 1-10 parts of liquorice, 1-10 parts of ginseng and 2-10 parts of honeysuckle. The Chinese medicinal composition has the remarkable effects of tonifying qi and nourishing blood, maintaining beauty and keeping young and improving sleep due to the mutual matching of the components, is a medicinal and edible traditional Chinese medicinal material or a traditional Chinese medicinal material capable of being used for health-care food, has long-term administration experience, and has no toxic or side effect.
Description
Technical Field
The application relates to a traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young, a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines.
Background
With the increase of the living pressure and the acceleration of the living rhythm of people, many people have the phenomena of deficiency of both qi and blood, insomnia and dreaminess, premature senility of skin and the like due to various unhealthy life modes such as over-fatigue, improper diet, staying up all night and the like. If the people do not tonify qi and nourish blood in time, the people can suffer from fatigue, palpitation, insomnia, sallow complexion, low immunity and the like, and are more prone to diseases, so that the normal life of the people is influenced; the sleeping quality also directly influences the physical state of people, the cognitive learning ability of people is reduced due to poor sleeping quality for a long time, the reaction is slow, the energy is not easy to concentrate, the morbidity of diseases such as obesity, hypertension, hyperlipidemia and diabetes is increased, and the health is seriously damaged.
The existing medicines have the effects of benefiting qi, nourishing blood, improving sleep and delaying skin aging.
Disclosure of Invention
In order to solve the problems, the application provides the traditional Chinese medicine composition for tonifying qi and nourishing blood and maintaining beauty and keeping young, and the preparation method and the application thereof, and the invention solves the problem that the effects of tonifying qi and nourishing blood, improving sleep and delaying skin aging in the existing medicine are not obvious.
The application discloses a traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young, which comprises the following raw materials in parts by weight: 125-145 parts of chicken embryo, 1-10 parts of astragalus membranaceus, 1-10 parts of liquorice, 1-10 parts of ginseng and 2-10 parts of honeysuckle.
Preferably, the traditional Chinese medicine composition comprises the following raw materials in parts by weight: 137 parts of chicken embryo, 3 parts of astragalus, 4 parts of liquorice, 2 parts of ginseng and 6 parts of honeysuckle.
The traditional Chinese medicine composition has the advantages that the components are matched with each other, the traditional Chinese medicine composition has remarkable effects of tonifying qi and nourishing blood, maintaining beauty and keeping young and improving sleep, all medicinal materials are medicinal and edible or traditional Chinese medicinal materials capable of being used as health-care food, the traditional Chinese medicine composition has long-term medication experience, and no toxic or side effect is caused.
Optionally, the feed comprises the following raw materials in parts by weight: 125-145 parts of chicken embryo, 1-10 parts of astragalus membranaceus, 1-10 parts of liquorice, 1-10 parts of ginseng, 2-10 parts of honeysuckle, 1-10 parts of fructus amomi, 1-10 parts of cinnamon, 1-10 parts of poria cocos and 2-10 parts of Chinese yam.
Optionally, the traditional Chinese medicine also comprises 2-10 parts of rose and 5-20 parts of Chinese date according to parts by weight.
Preferably, the feed comprises the following raw materials in parts by weight: 137 parts of chicken embryo, 3 parts of astragalus membranaceus, 6 parts of liquorice, 2 parts of ginseng, 6 parts of honeysuckle, 3 parts of fructus amomi, 3 parts of cinnamon, 4 parts of poria cocos, 6 parts of Chinese yam, 6 parts of rose and 10 parts of Chinese date.
Optionally, the feed comprises the following raw materials in parts by weight: 125-145 parts of chicken embryo, 1-10 parts of astragalus membranaceus, 5-20 parts of liquorice, 1-10 parts of ginseng, 2-10 parts of honeysuckle, 1-10 parts of fructus amomi, 1-10 parts of cinnamon, 1-10 parts of poria cocos, 5-20 parts of Chinese yam, 5-20 parts of cistanche, 2-10 parts of raspberry and 2-10 parts of wolfberry fruit.
Preferably, the feed comprises the following raw materials in parts by weight: 137 parts of chicken embryo, 3 parts of astragalus membranaceus, 10 parts of liquorice, 2 parts of ginseng, 6 parts of honeysuckle, 3 parts of fructus amomi, 3 parts of cinnamon, 4 parts of poria cocos, 12 parts of Chinese yam, 12 parts of cistanche, 6 parts of raspberry and 6 parts of wolfberry fruit.
Optionally, the feed comprises the following raw materials in parts by weight: 5-15 parts of astragalus membranaceus, 20-30 parts of cistanche, 2-10 parts of fructus amomi, 30-40 parts of liquorice, 7-17 parts of raspberry, 7-17 parts of wolfberry fruits, 20-30 parts of Chinese yams, 5-15 parts of poria cocos, 140-160 parts of chicken embryo, 2-10 parts of ginseng, 2-10 parts of cinnamon, 7-17 parts of honeysuckle, 25-35 parts of mulberries and 10-20 parts of hawthorn.
Optionally, the donkey-hide gelatin food further comprises 2-8 parts of donkey-hide gelatin according to parts by weight.
Optionally, the composition comprises the following components in parts by weight: 6-14 parts of astragalus membranaceus, 22-28 parts of cistanche, 3-9 parts of fructus amomi, 32-38 parts of liquorice, 9-15 parts of raspberry, 9-15 parts of wolfberry, 22-28 parts of Chinese yam, 7-13 parts of poria cocos, 145-160 parts of chicken embryo, 3-9 parts of ginseng, 3-9 parts of cinnamon, 9-15 parts of honeysuckle, 27-33 parts of mulberry and 12-18 parts of hawthorn.
Optionally, the composition comprises the following components in parts by weight: 6-14 parts of astragalus membranaceus, 22-28 parts of cistanche, 3-9 parts of fructus amomi, 32-38 parts of liquorice, 9-15 parts of raspberry, 9-15 parts of wolfberry, 22-28 parts of Chinese yam, 7-13 parts of poria cocos, 145-160 parts of chicken embryo, 3-9 parts of ginseng, 3-9 parts of cinnamon, 9-15 parts of honeysuckle, 27-33 parts of mulberry, 12-18 parts of hawthorn and 2-8 parts of donkey-hide gelatin.
Optionally, the composition comprises the following components in parts by weight: 12 parts of astragalus membranaceus, 28 parts of cistanche, 8 parts of fructus amomi, 38 parts of liquorice, 15 parts of raspberry, 15 parts of wolfberry fruit, 28 parts of Chinese yam, 12 parts of poria cocos, 155 parts of chicken embryo, 8 parts of ginseng, 8 parts of cinnamon, 15 parts of honeysuckle, 32 parts of mulberry and 18 parts of hawthorn.
Optionally, the composition comprises the following components in parts by weight: 10 parts of astragalus membranaceus, 25 parts of cistanche, 6 parts of fructus amomi, 35 parts of liquorice, 12 parts of raspberry, 12 parts of wolfberry fruit, 25 parts of Chinese yam, 10 parts of poria cocos, 150 parts of chicken embryo, 6 parts of ginseng, 6 parts of cinnamon, 12 parts of honeysuckle, 30 parts of mulberry, 15 parts of hawthorn and 5 parts of donkey-hide gelatin.
The donkey-hide gelatin is added in the traditional Chinese medicine composition, so that the parts of other components can be correspondingly reduced without weakening the efficacy of the traditional Chinese medicine composition, and the efficacies of the traditional Chinese medicine composition for tonifying qi and nourishing blood, maintaining beauty and keeping young and improving sleep can be further strengthened and consolidated; meanwhile, the problems of vigorous liver fire, excessive body supplement and the like caused by excessive other components can be avoided; and the preparation cost of the traditional Chinese medicine composition is reduced under the condition of ensuring the drug effect.
Optionally, the application provides a preparation method of the traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young, which comprises the following steps:
1) crushing ginseng into powder and donkey-hide gelatin into blocks for later use;
2) decocting 13 medicinal materials including astragalus, cistanche, fructus amomi, liquorice, raspberry, wolfberry fruit, Chinese yam, poria cocos, chicken embryo, cinnamon, honeysuckle, mulberry and hawthorn in water for 2-3 times, 1-2 hours each time, filtering for 2-3 times, merging filtrate, and concentrating the filtrate at 85-95 ℃ until the relative density is 1.05-1.10 to obtain final filtrate;
3) adding the ginseng powder and the donkey-hide gelatin blocks prepared in the step 1) into the final filtrate obtained in the step 2), uniformly mixing, continuously concentrating the filtrate at 85-95 ℃ until the relative density is 1.25-1.35, adding 240-260 parts by weight of seasoning accessories, uniformly mixing, and filling.
In the application, the ginseng is crushed into powder, and the donkey-hide gelatin is crushed into blocks so as to accelerate the dissolution speed of the ginseng and the donkey-hide gelatin in the filtrate and shorten the preparation time of the traditional Chinese medicine composition; meanwhile, the effects of the ginseng and the donkey-hide gelatin can be exerted more fully, and the materials are utilized more fully.
Preferably, the number of times of decocting with water in step 2) is 2, each time for 1 hour. Preferably, the number of filtrations in step 2) is 2.
Preferably, the concentration in step 2) is carried out at a temperature with a lower limit selected from 85 ℃, 88 ℃, 91 ℃ or 94 ℃ and an upper limit selected from 85 ℃, 88 ℃, 91 ℃ or 94 ℃.
Preferably, the lower limit of the relative density in step 2) is selected from 1.05, 1.07, 1.09 or 1.10 and the upper limit is selected from 1.05, 1.07, 1.09 or 1.10.
Most preferably, the temperature of concentration in step 2) is 90 ℃ and the relative density of the filtrate is 1.08.
Optionally, the flavoring auxiliary material in step 3) is honey, maltose syrup or glucose syrup. Preferably, the flavoring auxiliary in step 3) is maltose syrup.
Preferably, the lower limit of maltose syrup portion is selected from 246, 252, 258 or 260 and the lower limit is selected from 246, 252, 258 or 260.
Most preferably, the maltose syrup in step 3) is 250 parts. The malt syrup used in the application can be used for harmonizing the bitter taste of the traditional Chinese medicine composition, so that the traditional Chinese medicine composition has a better mouthfeel.
Preferably, the concentration in step 3) is carried out at a temperature with a lower limit selected from 85 ℃, 88 ℃, 91 ℃ or 94 ℃ and an upper limit selected from 85 ℃, 88 ℃, 91 ℃ or 94 ℃.
Preferably, the lower limit of the relative density in step 3) is selected from 1.25, 1.28, 1.31 or 1.34 and the upper limit is selected from 1.25, 1.28, 1.31 or 1.34.
Most preferably, the temperature of concentration in step 3) is 90 ℃ and the relative density of the filtrate is 1.30.
The concentration temperature in the step 2) and the step 3) in the application can enable the ginseng powder and the donkey-hide gelatin blocks to be better dissolved in the filtrate, and can ensure that the nutrient components of each component in the filtrate are not damaged; the relative density in the step 2) can enable the ginseng powder and the donkey-hide gelatin blocks to be better dispersed and dissolved in the filtrate, and if the relative density is too high, the ginseng powder and the donkey-hide gelatin blocks can be unevenly dispersed and dissolved, so that the efficacy of the traditional Chinese medicine composition is influenced; the relative density in the step 3) can make the prepared traditional Chinese medicine composition convenient for subsequent processing and production.
Optionally, the fineness of the ginseng powder is 80-120 meshes, and the fineness of the donkey-hide gelatin blocks is 3-7 meshes.
Optionally, the fineness ratio of the ginseng powder to the donkey-hide gelatin blocks is 18-23.
Preferably, the fineness of the ginseng powder has an upper limit selected from 85 meshes, 95 meshes, 105 meshes or 115 meshes and a lower limit selected from 85 meshes, 95 meshes, 105 meshes or 115 meshes. Most preferably, the fineness of the ginseng powder is 100 meshes, and the fineness of the donkey-hide gelatin block is 5 meshes.
Preferably, the fineness ratio of the ginseng powder to the donkey-hide gelatin block is 20. The fineness ratio of the ginseng powder to the donkey-hide gelatin blocks can enable the ginseng powder and the donkey-hide gelatin blocks to achieve the optimal dispersion and dissolution effects in a close time, so that the processing and preparation time is reduced, and the maximum effective content of the components of the traditional Chinese medicine composition can be ensured.
According to another aspect of the present application, there is provided a use of a traditional Chinese medicine composition for benefiting qi and nourishing blood, and maintaining beauty and keeping young, which prepares the prepared traditional Chinese medicine composition into a soft extract, a tablet, a capsule, an oral solution, a granule, a paste, a powder, an emulsion, a chewable matrix, a dietary supplement, a nutritional supplement, a beverage, a health food and a functional food.
Optionally, the application prepares the prepared traditional Chinese medicine composition into an oral solution;
the preparation method comprises the following steps:
1) mixing the plant materials uniformly, and pulverizing into coarse powder with a pulverizer; pulverizing the animal medicinal material chicken embryo into coarse powder by a pulverizer;
2) percolating and refining plant medicinal materials
2.1) adding 60-80% ethanol into the plant medicinal material coarse powder, stirring, fully infiltrating, moistening for 0.8-1.3 hours, loading into a percolation device, then adding 60-80% ethanol to submerge the medicinal materials, wherein the amount of the ethanol is 3-6 times of that of the medicinal materials, and percolating at a flow rate of one drop per second after soaking for 2-4 days and nights;
2.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at the temperature of 75-85 ℃ to obtain a plant medicinal material concentrated solution;
2.3) placing the concentrated solution of the plant medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the plant medicinal materials;
2.4) filtering;
3) percolation and refining of animal medicinal materials
3.1) adding 60-80% ethanol into animal medicinal material coarse powder, stirring, fully infiltrating, moistening for 0.8-1.3 hours, loading into a percolation device, then adding 60-80% ethanol to submerge the medicinal materials, wherein the amount of the ethanol is 3-6 times of that of the medicinal materials, and percolating at a flow rate of one drop per second after soaking for 2-4 days and nights;
3.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at 75-85 ℃ to obtain an animal medicinal material concentrated solution;
3.3) placing the concentrated solution of the animal medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, adding kaolin, fully and uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the animal medicinal materials;
3.4) filtering and clarifying, adding 1-3% of activated carbon, fully and uniformly stirring, boiling for 8-12 minutes, cooling to 45-50 ℃, and filtering and clarifying again;
4) mixing the animal medicine refined liquid and the plant medicine refined liquid, boiling for 8-12 minutes, cooling to 1-4 ℃, preserving heat, standing for 16-20 hours, filtering and clarifying to obtain a mixed refined liquid;
5) weighing a sweetening agent and potassium sorbate, preparing a 0.1-0.3% cardamom oil wine solution, adding purified water, the sweetening agent and the potassium sorbate into the mixed refined solution, stirring until the mixture is melted, then dripping the cardamom oil wine solution, stirring uniformly, and supplementing the purified water;
6) filtering the feed liquid obtained in the step 5), and refrigerating and storing filtrate;
7) and (6) filling and sterilizing.
Preferably, the application prepares the prepared traditional Chinese medicine composition into an oral solution;
the preparation method comprises the following steps:
1) mixing radix astragali, Cistanchis herba, fructus Amomi, Glycyrrhrizae radix, Rubi fructus, fructus Lycii, rhizoma Dioscoreae, Poria, ovum gallus Domesticus crusta, cortex Cinnamomi, flos Lonicerae, Mori fructus, and fructus crataegi uniformly, and pulverizing into coarse powder with pulverizer; pulverizing the animal medicinal material chicken embryo into coarse powder by a pulverizer;
2) percolating and refining plant medicinal materials
2.1) adding 70% ethanol into the coarse powder of the plant medicinal material, stirring, fully infiltrating, moistening for 1 hour, loading into a percolation device, then adding 70% ethanol to submerge the medicinal material, wherein the amount of the ethanol is 5 times of that of the medicinal material, and percolating at a flow rate of one drop per second after soaking for 3 days and nights;
2.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at 80 ℃ to obtain a plant medicinal material concentrated solution;
2.3) placing the concentrated solution of the plant medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, cooling the liquid to 3 ℃, preserving heat and standing for 18 hours to obtain refined solution of the plant medicinal materials;
2.4) filtering;
3) percolation and refining of animal medicinal materials
3.1) adding 70% ethanol into the animal medicinal material coarse powder, stirring, fully infiltrating, moistening for 1 hour, loading into a percolation device, then adding 70% ethanol to submerge the medicinal materials, wherein the ethanol amount is 5 times of the medicinal materials, and percolating at a flow rate of one drop per second after soaking for 3 days and nights;
3.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at 80 ℃ to obtain an animal medicinal material concentrated solution;
3.3) placing the concentrated solution of the animal medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, adding kaolin, fully and uniformly stirring, cooling the liquid to 3 ℃, preserving heat and standing for 18 hours to obtain refined solution of the animal medicinal materials;
3.4) filtering and clarifying, adding active carbon with the mass fraction of 2 percent of the refined liquid, fully and uniformly stirring, boiling for 10 minutes, cooling to 48 ℃, filtering and clarifying again;
4) mixing the refined liquid of animal medicinal materials and the refined liquid of plant medicinal materials, boiling for 10 min, cooling to 3 deg.C, standing for 18 hr, filtering, and clarifying to obtain mixed refined liquid;
5) weighing sweetener and potassium sorbate, preparing 0.2% cardamom oil wine solution, adding purified water, sweetener and potassium sorbate into the mixed refined solution, stirring to melt, adding the cardamom oil wine solution dropwise, stirring, and supplementing purified water;
6) filtering the feed liquid obtained in the step 5), and refrigerating and storing filtrate;
7) and (6) filling and sterilizing.
Optionally, the medicinal materials are radix astragali, herba cistanches, fructus Amomi, radix Glycyrrhizae, fructus Rubi, fructus Lycii, rhizoma Dioscoreae, Poria, embryo gallus domesticus, cortex Cinnamomi, flos Lonicerae, fructus Mori, fructus crataegi, colla Corii Asini, radix Ginseng, flos Rosae Rugosae, and fructus Jujubae.
The effects of the medicinal materials in the application are as follows:
astragalus root: has effects of invigorating qi, consolidating exterior, promoting urination, expelling toxin, expelling pus, healing sore, and promoting granulation. Modern pharmacological research shows that astragalus has the effects of improving immunity, enhancing oxidation resistance, resisting myocardial ischemia, eliminating free radicals, resisting tumors, resisting aging and the like.
Cistanche deserticola: modern pharmacology shows that the cistanche has a plurality of pharmacological actions of regulating immune activity, resisting aging, improving learning and memory ability, protecting nerves, resisting viruses and tumors, influencing intestinal flora and the like.
Amomum fruit: resolving dampness, promoting appetite, warming spleen, relieving diarrhea, resisting ulcer, resisting inflammation, resisting blood platelet aggregation, and prolonging blood coagulation time.
Raspberry: the health-care tea has the effects of tonifying kidney, controlling nocturnal emission, reducing urination, nourishing liver and improving eyesight, and has obvious activity in the aspects of resisting tumors, resisting aging, removing free radicals and the like as effective components of terpenes, flavones, alkaloids, coumarins and the like.
Wolfberry fruit: nourishing liver and kidney, clearing away heat, improving eyesight, enhancing immunity, resisting aging, tumor, stress and blood sugar, reducing blood lipid, protecting eye, and resisting oxygen free radical injury.
Chinese yam: the Chinese medicinal composition has the effects of invigorating spleen, tonifying lung, reinforcing kidney and replenishing vital essence, and has the biological activities of resisting tumor, regulating immunity, resisting oxidation, resisting diabetes, resisting mutation and the like.
Tuckahoe, poria cocos: has effects in nourishing brain, strengthening body constitution, invigorating spleen, regulating stomach function, increasing myocardial blood flow, promoting urination, protecting liver, relieving inflammation, resisting oxidation, promoting immunity, and delaying aging.
Chicken embryo: the chicken embryo contains rich amino acids, lecithin, unsaturated fatty acid, calcium, zinc, iron, vitamins and other nutrient components, and has the functions of strengthening body constitution, nourishing brain, tranquilizing, resisting senility, tonifying deficiency and nourishing vitality.
Ginseng: has effects of invigorating primordial qi, recovering pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, nourishing blood, tranquilizing mind, and improving intelligence. The main components are saccharides, saponins, proteins, polypeptides and the like, and the health-care food has the pharmacological effects of improving memory and immunity, improving cardiovascular and cerebrovascular diseases, delaying aging, reducing blood sugar, resisting tumors and the like.
Cinnamon: has effects in tonifying yang, warming kidney, dispelling cold, dredging collaterals, relieving pain, resisting gastric ulcer, resisting inflammation, resisting bacteria, resisting tumor, tranquilizing mind, relieving spasm, and relieving fever, and contains polysaccharides, polyphenols, coumarin and inorganic elements.
Honeysuckle flower: clearing away heat and toxic material, eliminating swelling and dispersing carbuncle, and has the functions of resisting pathogenic microbe, resisting inflammation, resisting virus, clearing away heat, reducing blood fat, etc.
And (3) mulberry fruit: as a food with homology of medicine and food, contains effective components such as anthocyanin, polysaccharide, resveratrol, water-soluble protein and the like, and has pharmacological effects of reducing blood sugar, resisting oxidation, protecting immunity, recovering motor function, protecting kidney, protecting spleen, inhibiting bacteria, resisting inflammation and the like.
Hawthorn fruit: the hawthorn has the effects of strengthening spleen, stimulating appetite, promoting digestion, removing food stagnation, promoting blood circulation, reducing phlegm, expelling tapeworm, treating hernia, promoting growth and the like, and modern researches find that the hawthorn can reduce blood pressure, reduce blood fat, resist atherosclerosis, arrhythmia, myocardial ischemia, inhibit brain cell apoptosis and the like when being applied to a cardiovascular system and a cerebrovascular system.
Licorice root: invigorating spleen and qi, clearing away heat and toxic materials, moistening lung, arresting cough, and harmonizing the above materials.
E, donkey-hide gelatin: is a good tonic, and is especially a holy product for women, which can beautify skin, enrich blood and tonify qi. It has the following main effects: 1. for nourishing yin and tonifying blood, it is combined with E jiao to nourish yin and tonify blood. 2. Nourishing yin and moistening dryness, and can be used for treating cough due to yin deficiency and hyperactivity of heart fire, lung deficiency with heat, and yin and blood deficiency. 3. The product is a good product for nourishing skin and maintaining beauty. 4. Blood nourishing and hemostasis, pulmonary tuberculosis hemoptysis, thrombocytopenic hemorrhage, etc. 5. Regulating menstruation and preventing miscarriage, so it can nourish fetus, prevent miscarriage and regulate and treat pregnancy.
Chinese date: has sweet and warm nature and taste, and has effects of invigorating stomach, invigorating spleen, replenishing blood, nourishing, and strengthening body constitution. Enhancing immunity, protecting liver, lowering blood pressure, and protecting heart. Beautifying, whitening and removing freckles. Delaying senility. To invigorate qi and nourish blood.
And (3) rose: bitter and cold; has little toxicity. Enter lung and large intestine meridians, clear away heat and toxic material, and dispel dampness. Has effects of warming and nourishing blood vessels, warming stomach and nourishing stomach, relieving gastrointestinal nerve, moistening skin, removing black speck, improving skin color, and can be used for adjuvant treatment of female dysmenorrhea, menoxenia, etc. Has effects in promoting wound healing, promoting digestion, eliminating fat, and caring skin.
Benefits that can be produced by the present application include, but are not limited to:
1. the traditional Chinese medicine composition for tonifying qi, nourishing blood, maintaining beauty and keeping young, provided by the application, has the remarkable effects of tonifying qi, nourishing blood, maintaining beauty and keeping young and improving sleep by mutually matching the components, is a traditional Chinese medicine which can be used as both medicine and food or can be used for health food, has long-term medication experience, and has no toxic or side effect.
2. The traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young, provided by the application, has no bitter and astringent taste or peculiar smell of traditional Chinese medicine materials, has good taste and is easily accepted by people taking medicines.
3. The traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young, provided by the application, has the advantages that the concentration temperature in the processing and preparation process can enable the ginseng powder and the donkey-hide gelatin blocks to be better dissolved in the filtrate, and the nutrient components of all components in the filtrate can be guaranteed not to be damaged; the relative density in the preparation step 2) can enable the ginseng powder and the donkey-hide gelatin blocks to be better dispersed and dissolved in the filtrate, and if the relative density is too high, the ginseng powder and the donkey-hide gelatin blocks are not uniformly dispersed and dissolved, so that the efficacy of the traditional Chinese medicine composition is influenced.
4. According to the traditional Chinese medicine composition for tonifying qi, nourishing blood, maintaining beauty and keeping young, the fineness ratio of the ginseng powder to the donkey-hide gelatin blocks can enable the ginseng powder and the donkey-hide gelatin blocks to achieve the optimal dispersing and dissolving effects in a similar time, the processing and preparation time is shortened, and the maximum effective content of the components of the traditional Chinese medicine composition can be guaranteed.
Detailed Description
The present application will be described in detail with reference to examples, but the present application is not limited to these examples.
Unless otherwise specified, the raw materials and reagents in the examples of the present application were all purchased commercially.
Example 1
Preparation of composition No. 1
1) Pulverizing 6 parts of Ginseng radix into powder with fineness of 100 mesh, crushing 5 parts of colla Corii Asini into blocks with fineness of 5 mesh, and the fineness ratio of Ginseng radix powder and colla Corii Asini blocks is 20;
2) decocting 13 kinds of medicinal materials including 10 parts of astragalus membranaceus, 25 parts of cistanche, 6 parts of fructus amomi, 35 parts of liquorice, 12 parts of raspberry, 12 parts of wolfberry fruit, 25 parts of Chinese yam, 10 parts of poria cocos, 150 parts of chicken embryo, 6 parts of cinnamon, 12 parts of honeysuckle, 30 parts of mulberry and 15 parts of hawthorn in water for 2 times, filtering for 2 times each time for 1 hour, combining the filtrates, and concentrating the filtrate at 90 ℃ until the relative density is 1.08 to obtain the final filtrate;
3) adding the ginseng powder and the donkey-hide gelatin blocks prepared in the step 1) into the final filtrate obtained in the step 2), uniformly mixing, continuously concentrating the filtrate at 90 ℃ until the relative density is 1.30, adding 250 parts of malt syrup according to the parts by weight, uniformly mixing, and filling.
According to the parts of the medicinal materials in the composition 1#, the compositions 1# to 3# and the comparative compositions 1# to 5# are respectively prepared, and the difference of the preparation method and the preparation method of the composition 1# is shown in Table 1.
TABLE 1
Compositions 1# to 3# and comparative compositions 1# to 5# were characterized for efficacy as shown in table 2. The characteristics are divided into two parts, one part is sensory index, and the other part is physicochemical index. Sensory indicators include taste; physical and chemical indexes: the effective components in the traditional Chinese medicine comprise alkaloid and other substances, and the content of total alkaloid in the traditional Chinese medicine composition is measured by an ultraviolet spectrophotometry; (2) the viscosity of the Chinese medicinal composition is measured by a rotational viscometer.
TABLE 2
Serial number | Total alkaloid content (%) | Viscosity (cP) | Taste of the product |
1# | 28 | 10080 | No bitter and astringent taste, slight sweet |
2# | 25 | 9520 | No bitter and astringent taste, slight sweet |
3# | 23 | 11300 | No bitter and astringent taste, slight sweet |
Comparative composition No. 1 | 8 | 10004 | No bitter and astringent taste, slight sweet |
Comparative composition No. 2 | 22 | 4708 | No bitter and astringent taste, slight sweet |
Comparative composition No. 3 | 26 | 9984 | Has little fishy smell and is sweet and greasy |
Comparative composition No. 4# | 18 | 9458 | No bitter and astringent taste, slight sweet |
Comparative composition No. 5 | 11 | 8840 | Has solid granular feeling and is slightly sweet |
The comparison of the composition No. 1 to No. 3 shows that the traditional Chinese medicine composition prepared according to the parameter range of the preparation method provided by the application has no obvious difference in the overall components and the characterization parameters, and can achieve the required effect.
As can be seen from the comparison between the composition 1# and the comparative composition 1#, the concentration temperature in the step 2) and the step 3) can affect the content of the effective components of the prepared traditional Chinese medicine composition, and the alkaloid in the traditional Chinese medicine composition can be damaged when the concentration temperature is too high, so that the effective content in the traditional Chinese medicine composition is obviously reduced.
As can be seen from the comparison between the composition No. 1 and the comparative composition No. 2, the setting of the relative density finally affects the viscosity of the prepared traditional Chinese medicine composition, and the traditional Chinese medicine composition is too thin due to too low viscosity and difficult to be processed into different dosage forms subsequently.
As can be seen by comparing the composition No. 1 with the comparative composition No. 3, the addition of the maltose syrup with the same parts can harmonize the taste of the prepared traditional Chinese medicine composition, and the honey can make the taste of the traditional Chinese medicine composition sweet and greasy without completely eliminating fishy smell.
As can be seen from composition No. 1, comparative composition No. 4 and comparative composition No. 5, if the mesh number of the ginseng powder and the donkey-hide gelatin block is larger, the content of the total alkaloids in the traditional Chinese medicine composition is reduced after heating and concentrating; if the mesh number of the ginseng powder and the donkey-hide gelatin block is smaller, the ginseng powder and the donkey-hide gelatin block cannot be completely melted in the heating concentration process, so that the content of total alkaloids in the final traditional Chinese medicine composition is greatly reduced, the taste is not good, obvious granular sensation exists, and in the preparation process, if the fineness ratio of the ginseng powder to the donkey-hide gelatin block is not in a proper range, the dispersibility of the ginseng powder and the donkey-hide gelatin block is poor, and the taste and the production quality of the product are influenced.
Example 2
The preparation method of the other traditional Chinese medicine composition comprises the following steps:
1) mixing the plant medicinal materials uniformly, and crushing the mixture into plant medicinal material coarse powder by a crusher; pulverizing the animal medicinal material chicken embryo into animal medicinal material coarse powder by a pulverizer;
2) percolating and refining plant medicinal materials
2.1) adding 60-80% ethanol into the coarse powder of the plant medicinal material, stirring, fully infiltrating, moistening for 0.8-1.3 hours, filling into a percolation device, then adding 60-80% ethanol to submerge the medicinal material, wherein the amount of the ethanol is 3-6 times of that of the medicinal material, and percolating at a flow rate of one drop per second after soaking for 2-4 days;
2.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at the temperature of 75-85 ℃ to obtain a plant medicinal material concentrated solution;
2.3) placing the concentrated solution of the plant medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the plant medicinal materials;
2.4) filtering;
3) percolation and refining of animal medicinal materials
3.1) adding 60-80% ethanol into animal crude powder, stirring, fully infiltrating, moistening for 0.8-1.3 hours, loading into a percolation device, then adding 60-80% ethanol to submerge the crude powder, wherein the amount of the ethanol is 3-6 times of that of the crude powder, and percolating at a flow rate of one drop per second after soaking for 2-4 days;
3.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at 75-85 ℃ to obtain an animal medicinal material concentrated solution;
3.3) placing the concentrated solution of the animal medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, adding kaolin, fully and uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the animal medicinal materials;
3.4) filtering and clarifying, adding 1-3% of activated carbon, fully and uniformly stirring, boiling for 8-12 minutes, cooling to 45-50 ℃, and filtering and clarifying again;
4) mixing the animal medicine refined liquid and the plant medicine refined liquid, boiling for 8-12 minutes, cooling to 1-4 ℃, preserving heat, standing for 16-20 hours, filtering and clarifying to obtain a mixed refined liquid;
5) weighing a sweetening agent and potassium sorbate, preparing a 0.1-0.3% cardamom oil wine solution, adding purified water, the sweetening agent and the potassium sorbate into the mixed refined solution, stirring until the mixture is melted, then dripping the cardamom oil wine solution, stirring uniformly, and supplementing the purified water;
6) filtering the feed liquid obtained in the step 5), and refrigerating and storing filtrate;
7) and (6) filling and sterilizing.
It is to be understood that the preparation method of example 1 in the present application is generally used for preparing a paste, and the preparation method of example 2 is generally used for preparing an oral liquid.
Example 3
Samples # 1 to # 15 and comparative sample # 1 were prepared by either of the above-described preparation methods of example 1 or example 2, and the differences in formulation from sample # 1 are shown in table 3.
TABLE 3
Example 4 characterization of the mouse experiment
The drugs used in the following experimental sample No. 1 to sample No. 15 and comparative sample No. 1 are all sample No. 1 to sample No. 15 and comparative sample No. 1 prepared in example 3.
Experiment one: qi and blood deficiency mouse experiment
1. Modeling
The method is characterized in that a ' tail-cutting bloodletting and intraperitoneal injection of cyclophosphamide ' of a mouse ' is adopted for molding, NIH male mice are fed for 3 days in an adaptive mode, 20 mice are randomly grouped according to weight, namely a blank control group, a model control group, a sample 1# group-sample 15# group, a comparison sample 1# group and a positive control group, the drug amount of each group is 10g/kg, and the positive control group adopts commercially available compound donkey-hide gelatin syrup. The mice of each group are administered by intragastric administration, the model control group and the blank control group are administered by intragastric administration of physiological saline with the same amount, the intragastric administration volume is 20ml/kg, 1 time/day, and the administration is continuously carried out for 10 days. On the 4 th, 6 th and 8 th days after the first administration, 0.25ml/10g of tail vein bleeding of the model group and the administration group, on the 5 th, 7 th and 9 th days, 40mg/kg of cyclophosphamide is injected into the abdominal cavity of mice of the model group and the administration groups, and 30mg/kg of normal saline is injected into the abdominal cavity of mice of the blank group, so that the animal model with deficiency of both qi and blood is prepared.
2. Experimental methods
After the administration group is administered for 1 hour for the last time, randomly selecting 10 mice per group, carrying out eyeball blood collection, and measuring Red Blood Cells (RBC), hemoglobin (Hb) and Platelets (PLT) by an automatic whole blood analyzer after blood collection; at the same time, serum is separated and collected according to a conventional method, and the contents of Erythropoietin (EPO), interleukin-2 (IL-2) and interleukin-3 (IL-3) in the serum are measured by an enzyme-linked immunosorbent assay.
After 1h of the last gavage of the dosing group, the remaining mice of each group were subjected to a bar-rotating test. The function coordinated movement of the mouse is observed at 16r/min through a rotating rod type fatigue instrument, and the residence time of the mouse on the rotating rod within 3min is recorded. If the mouse did not drop throughout the procedure, the mouse rod-rotating residence time was 180 s.
The tail of each group of mice is a certain weight (5 percent of the weight) and placed in a smooth swimming cylinder with the inner wall at the water temperature of 25-30 ℃ for swimming, and the control group and the administration group are alternately carried out. The stopwatch records the time from the beginning of swimming after the mouse is put into water to death, namely the swimming time.
The data analysis adopts a statistical method, SPSS 16.0 software is used for processing the obtained data, One-way ANOVA is selected for statistical analysis, and the data is analyzed byAnd (4) showing. Two by two comparisons with T test, with P<0.05 is a significant difference, P<0.01 is a very significant difference, which has statistical significance.
3. Results of the experiment
The control group mice have bright hair color, normal appetite and defecation and flexible action; the hair color of the mice in the model group is dull and easy to fall off, anorexia, loose and wet stool, dislike activity, crouch, arch back and somnolence; the mouse hair color, appetite, defecation condition and activity of the sample 1# to 15# group and the comparative sample 1# group are obviously improved compared with the model group, the mice of the sample 1# to 15# group have no obvious difference, the mice of the comparative sample 1# group have certain improvement compared with the model group, but the effect of the mice of the comparative sample 1# group is obvious without the sample 1# to 15# group, and the effects of the mice of the sample 4# group, the sample 5# group and the sample 7# to 15# group without donkey-hide gelatin are poorer than those of the mice of other donkey-hide gelatin added sample groups.
Compared with a blank control group, the WBC, RBC, Hb and PLT contents of the mice in the model control group are all obviously reduced (P is less than 0.01), and the success of modeling is shown; compared with a model group, the sample 1# to 15# and the positive drug group can obviously increase Hb and PLT contents (P is less than 0.01), the comparative sample 1# has an increasing effect, but is not as obvious as other sample groups, and the sample 4# group, the sample 5# group and the sample 7# to 15# group which are not added with donkey-hide gelatin increase Hb and the PLT contents are poorer than other sample groups; the sample No. 1-15 group and the positive control group can obviously increase the WBC content (P <0.01 or P <0.05), the comparative sample No. 1 group has the increasing effect, but is not as obvious as other sample groups, and the sample No. 4, sample No. 5 and sample No. 7-15 groups which are not added with the donkey-hide glue have lower WBC content than other sample groups; the sample 1# to 15# group and the positive group can significantly increase the RBC content (P <0.01 or P <0.05), and the comparative sample 1# group has no significant difference (P > 0.05). The WBC, RBC and Hb levels of the sample 1# group, the sample 2# group, the sample 3# group, the sample 6# group and the positive group were not significantly different compared with the normal group, and were close to the normal group level, and the results are shown in table 4.
TABLE 4 data of WBC, RBC, Hb, PLT for each group of mice with deficiency of both Qi and blood
Note: p <0.05, P < 0.01; compared to the blank group, # P <0.05, # P < 0.01.
Compared with a blank control group, the contents of EPO and IL-3 in the model control group are obviously reduced (P is less than 0.01), and the content of IL-2 is obviously increased (P is less than 0.01); compared with the model group, the samples 1# to 15# can obviously increase the content of EPO (P <0.01 or P <0.05), the samples 1# group, 2# group, 3# group, 4# group, 5# group, 6# group, 8# group, 11# group, 12# group, 13# group, 14# group, 15# group and the positive control group can obviously reduce the content of IL-2 (P <0.01 or P <0.05), the samples 7# group, 9# group, 10# group and the comparative sample 1# group have the tendency of reducing IL-2, but the difference is not significant (P >0.05), the IL-3 content can be increased significantly in the group of sample No. 1, the group of sample No. 2, the group of sample No. 3 and the positive control group (P <0.01 or P <0.05), and the groups of sample No. 4-15 and the group of comparative sample No. 1 have increasing tendency but have no significant difference (P > 0.05). Compared with the blank group, the EPO, IL-2 and IL-3 contents of the sample No. 1 group and the sample No. 2 group have no significant difference (P is more than 0.05), and the results are shown in the table 5.
TABLE 5 data of groups of mice with deficiency of both qi and blood EPO, IL-2, IL-3
Note: p <0.05, P < 0.01; compared to the blank group, # P <0.05, # P < 0.01.
Compared with a blank control group, the time of the model control group mouse on a rotating rod and the swimming time are obviously reduced, which indicates that the model is successfully made (P is less than 0.01); the sample 1# group, sample 2# group, sample 3# group, sample 4# group, sample 5# group, sample 6# group, sample 8# group, sample 11# group, sample 14# group and positive control group significantly increased the mouse rotarod movement and swimming movement time (P <0.01 or P <0.05) compared to the model group. Compared with the blank group, the swimming time of the sample No. 1 group, the sample No. 2 group, the sample No. 3 group and the sample No. 6 group is close to the level of the blank group, no significant difference (P >0.05) exists, and the swimming time of the sample No. 4 group, the sample No. 5 group and the sample No. 7-15 group which are not added with the donkey-hide gelatin are slightly shorter than those of other sample groups on a rotating rod. The results are shown in Table 6.
TABLE 6 data of the time of the rod-rotating exercise and swimming exercise for each group of mice with deficiency of both qi and blood
Group of | Dosage (g/kg) | Time on rotating bar(s) | Swimming time(s) |
Blank control group | 0 | 151.00±16.23** | 311.00±42.89** |
Model control group | 0 | 92.51±14.74## | 214.56±84.00## |
Positive control group | 10 | 119.54±13.82**## | 299.54±35.81** |
Sample No. 1 group | 10 | 125.11±24.86**## | 305.11±37.59** |
Sample No. 2 group | 10 | 120.91±28.99**## | 299.91±41.55** |
Sample No. 3 group | 10 | 119.56±25.66**## | 300.51±48.77** |
Sample No. 4 group | 10 | 105.32±28.22*## | 280.56±54.55*# |
Sample No. 5 group | 10 | 104.89±21.35*## | 280.95±58.33*# |
Sample No. 6 group | 10 | 118.98±28.45**## | 301.10±58.21** |
Sample 7# group | 10 | 99.18±22.14## | 248.25±50.21## |
Sample No. 8 group | 10 | 104.51±17.12*## | 279.81±49.54*# |
Sample No. 9 group | 10 | 99.62±24.71## | 260.48±39.61# |
Sample No. 10 group | 10 | 99.68±20.37## | 251.29±42.47# |
Sample No. 11 group | 10 | 104.72±18.20*## | 280.34±50.21*# |
Sample No. 12 group | 10 | 100.01±22.31## | 264.05±42.18*# |
Sample No. 13 group | 10 | 100.42±20.12## | 273.17±42.15*# |
Sample No. 14 group | 10 | 107.49±25.21*## | 285.61±44.01* |
Sample No. 15 group | 10 | 101.95±19.55## | 274.61±39.64*# |
Comparative sample No. 1 group | 10 | 100.56±28.85## | 243.51±59.43## |
The results show that the samples 1# to 15# all obviously inhibit the reduction of RBC, WBC, Hb and PLT caused by deficiency of both qi and blood; the rod rotating time and the load swimming time of the mouse can be prolonged to different degrees; obviously increases the EPO content in the serum of the mouse, increases the IL-3 content in the serum of the mouse and reduces the IL-2 content in the serum of the mouse in different degrees. The comparative sample # 1 group using the comparative sample # 1 with the changed number of parts had some effect, but the effect was not significant, compared to the comparative sample # 1 group. The group 4, 5 and 7# to 15# samples, to which no donkey-hide gelatin was added, were slightly less effective than the other groups. The result shows that the traditional Chinese medicine composition prepared by the application can improve general physical signs of mice with deficiency of both qi and blood, and has remarkable effects of resisting deficiency of both qi and blood and resisting fatigue.
Experiment two: mouse experiment for delaying skin aging
1. Modeling
A model of mice aging is induced by combining D-galactose and ultraviolet irradiation. Selecting Kunming mice which are female and have the weight of 18-22 g, and randomly grouping: sample # 1 to sample # 15, control sample # 1, model control, blank control and positive control. The back of the mice had been depilated by about 5cm × 5cm, and the group except the blank group was given 1% D-galactose 1ml/100g subcutaneously to the neck and back daily, and subjected to UVB ultraviolet irradiation for 30 min/day for 42 days to create a subacute aging model, and the blank group was given the same dose of physiological saline. The traditional Chinese medicine composition prepared by intragastric administration of the model group, the sample No. 1 group, the sample No. 15 group and the comparison sample No. 1 group, and the vitamin E solution for intragastric administration of the positive group is 50mg/kg once a day for 42 days continuously.
2. Experimental methods
After each administration group is administered for 1h, blood is taken from eye sockets of mice, centrifuged, and the supernatant is taken to measure the content of superoxide dismutase (SOD) and Malondialdehyde (MDA). Removing back hair, shearing back skin, defatting, homogenizing tissue, and collecting supernatant to detect SOD and MDA content.
The data analysis adopts a statistical method, SPSS 16.0 software is used for processing the obtained data, One-way ANOVA is selected for statistical analysis, and the data is analyzed byAnd (4) showing. Two by two comparisons with T test, with P<0.05 is a significant difference, P<0.01 is a very significant difference, which has statistical significance.
3. Principle of experiment
D-galactose is injected subcutaneously, and the galactitol which is a metabolite of the D-galactose cannot be further metabolized by cells and is accumulated in the cells, so that the normal osmotic pressure is influenced, the cells are swollen, and simultaneously, a large amount of free radicals generated by the oxidation of the D-galactose in vivo exceed the scavenging capacity of a body, so that the lipid peroxidation is initiated to cause the degenerative change and the functional change of the animal tissue cells during aging, and researches show that the aging degree of the model is close to the 21-month age level of mice, and the changes are consistent with the natural aging change. Ultraviolet irradiation can affect the growth, metabolism and other functions of fibroblast cells in the dermis, and belongs to an exogenous factor of aging molding.
SOD is the main antioxidant enzyme for eliminating free radicals of the organism, can reduce the generation of oxygen free radicals and lipid peroxide, the oxygen free radicals are increased along with the increase of the age, and meanwhile, if the activity of SOD in the body is reduced, the oxygen free radicals are accumulated, so that the organism is quickly aged; therefore, the activity of serum and skin SOD is closely related to aging, and can indirectly reflect the capability of organism to remove oxygen free radicals. The MDA which is the final product of the decomposition of the lipid peroxide is an extremely active cross-linking agent and can be cross-linked with protein, nucleic acid and the like so as to denature and inactivate the lipid peroxide, and the cross-linked substances are accumulated in cells to form lipofuscin and enable the skin to have color spots and the like, so the MDA content can indirectly reflect the degree of damage of tissue cells by free radicals.
Whether the skin is kept smooth and tender mainly depends on the collagen under the dermis, Hyp is the amino acid with the highest content and the most stable in the collagen, is obtained by hydroxylating proline and accounts for about 13% of the total amount of the collagen amino acid, when the skin is aged, the crosslinking of collagen fibers and other macromolecules is increased, and under the action of free radicals, the macromolecular crosslinking is generated to reduce the activity of the hydroxylamidoyl hydroxylase, so that the hydroxylation of the proline is weakened, the content of hydroxyproline is reduced, and the synthesis of the collagen is further influenced. So that its content reflects the degree of aging of the animal skin.
4. Results of the experiment
The test result shows that the SOD content of the D-galactose aging model is obviously reduced (P is less than 0.01) compared with that of the blank group, and the MDA content is obviously increased (P is less than 0.01), which indicates that the molding is successful. The positive control group and the 16 sample groups can effectively reverse the D-galactose induced change, and compared with the model group, the mouse serum SOD activity of the sample No. 1 to 15 and the mouse serum SOD activity of the comparative sample No. 1 are obviously improved (P <0.01), and the MDA content is obviously reduced, (P <0.01) wherein the sample No. 1 group, the sample No. 2 group, the sample No. 3 group and the sample No. 6 group are close to the normal group level (P >0.05), and the table 7 shows.
TABLE 7 SOD activity and MDA content in serum of each group of mice
The test result shows that the D-galactose effectively replicates a mouse model of skin aging, and the SOD activity, the Hyp content and the MDA content of the skin of the mouse model are all significantly different from those of a blank control group (P < 0.01). Compared with the model group, the positive control group and the samples 1# to 15# can obviously improve the activity of SOD and the skin moisture percentage in the skin tissues of mice (P <0.01 and P <0.05) and obviously reduce the MDA content (P <0.01), and the samples 1# group, 2# group, 3# group, 4# group, 5# group, 6# group, 8# group, 10# group, 11# group, 12# group, 13# group, 14# group and 15# group can obviously improve the Hyp content (P <0.01 and P < 0.05). The sample 7# group, the sample 9# group, and the comparative sample 1# group had some effect, which was not as significant as the other sample groups. The group 4, 5 and 7# to 15# samples, to which no donkey-hide gelatin was added, were slightly less effective than the other groups. Wherein the level of the sample No. 1 group is close to that of the positive control group, the difference is less significant, the SOD activity and the skin water content of the sample No. 1 group are close to that of the blank group (P >0.05), and no significant difference exists, as shown in Table 8.
TABLE 8 SOD activity, MDA and Hyp content in skin tissue of mice in each group
The results show that the SOD activity and the MDA content of the serum and the skin tissues of the mice aged by the D-galactose can be obviously improved and reduced by each administration group, which indicates that the traditional Chinese medicine composition prepared by the application can improve the activity of antioxidant enzyme and reduce the generation of lipid peroxide. The experimental result shows that the Hyp content of the skin tissue of mice in each administration group is increased in different degrees through the intervention of the traditional Chinese medicine composition, so that the synthesis of skin collagen is promoted, and the effects of enhancing the skin elasticity and delaying the skin aging are prompted.
The samples prepared by the method have stronger antioxidant bioactivity, and the aging of skin is obviously delayed in the 1# group to the 15# group. The comparative sample No. 1 group with the modified formulation had some effect but the effect was not significant compared to the comparative sample No. 1 group. The group of sample 4#, sample 5#, sample 7#, sample 8#, sample 9#, sample 10#, sample 11#, sample 12#, sample 13#, sample 14# and sample 15# to which no donkey-hide gelatin was added were slightly less effective than the other sample groups. The traditional Chinese medicine composition prepared by the application has a remarkable effect of delaying skin aging.
Experiment three: mouse experiment for improving sleep
1. Modeling
An ICR mouse is selected to research the sleep improvement effect of the traditional Chinese medicine composition prepared by the application. ICR mice were female, weighing 20 ± 2g, and after 7 days of acclimation, were randomly grouped: the positive control group comprises 10 samples from the 1# group to the 15# group, a comparison sample from the 1# group and the blank control group, the 1# group to the 15# group and the 1# group are orally administrated with gastric lavage respectively, the gastric lavage amount is 20ml/kg, the continuous administration is carried out for 28 days, the positive control group is perfused with the traditional Chinese medicine tea for aiding sleep with the same volume, and the blank control group is perfused with the distilled water with the same volume.
2. Experimental methods
(1) General behavioral observations
The behavior state of the mice is observed every day, the mental state and behavior of the mice in the administration group are not obviously different from those of the control group, and the hair color of the mice in the administration group with different dosages is glossy compared with that of the control group. Before and after the start of the experiment, the mice were weighed to observe the change in body weight. The weight data are subjected to t-test by using SPSS software, the results are shown in Table 9, and the weights of mice in different dose administration groups and control groups have no significant difference (P is more than 0.05), namely, the traditional Chinese medicine composition prepared by the application has no significant influence on the weights of the mice, which shows that the traditional Chinese medicine composition in the dose of the application has no adverse influence on the weights of the mice.
TABLE 9 body weight results of mice before and after the experiment
(2) Direct sleep experiment
After each administration group was last administered for 30min, the control group and each administration group were observed for sleep. The sleep takes the disappearance of righting reflex as an index, if the righting reflex is not righted after exceeding 60s, the righting reaction is disappeared, and the mouse enters the sleep. The result shows that the mice of the blank control group and the administration group do not have direct sleep after the mice are administered with the test drug for 30min, which indicates that the traditional Chinese medicine composition prepared by the application has no direct sleep effect.
(3) Experiment for prolonging sleep time of sodium pentobarbital
After each administration group is administered for 15min at the last time, the intraperitoneal injection of 50mg/kg of pentobarbital sodium is performed on mice of each group, the injection amount is 0.1ml/10g, the starting and ending time of the disappearance of the positive reflex is taken as an index, and whether the test medicament can prolong the sleep time induced by the pentobarbital sodium is observed. The result shows that under the hypnotic effect of 50mg/kg sodium pentobarbital, the sleep time of the mice in each administration group is greatly prolonged (P <0.01) compared with that of a blank control group, the sleep time of the mice in a positive control group is remarkably prolonged (P <0.05) compared with that of the blank control group, but the sleep time of the mice in each administration group is shorter; the group of sample No. 1, the group of sample No. 2, the group of sample No. 3, the group of sample No. 6 and the group of sample No. 14 have very significant differences ((P <0.01) compared with the positive control group, and the group of sample No. 4, the group of sample No. 5, the group of sample No. 7, the group of sample No. 8, the group of sample No. 9, the group of sample No. 10, the group of sample No. 11, the group of sample No. 12, the group of sample No. 13, the group of sample No. 15 and the group of comparative sample No. 1 have no significant differences (P >0.05) compared with the positive control group.
TABLE 10 sleep time of mice in each group
Note: "+" indicates experimental groups compared to blank control groups,. + -. P <0.05,. + -. P < 0.01; "#" indicates that # P <0.05 and # P <0.01 in the experimental group compared with the positive group.
(4) Pentobarbital sodium subthreshold dose hypnosis experiment
Before the experiment begins, a subthreshold dose investigation experiment of the sodium pentobarbital is carried out, namely the maximum dose of the sodium pentobarbital which does not disappear in 80-90% of mouse positive reaction. After administration for 15min, 30mg/kg of sodium pentobarbital is intraperitoneally injected into each group of mice, and the injection amount is 0.1ml/10 g. The standard of falling asleep is 60s when the mouse positive reflection disappears. And recording the sleep number of the mice within 30min, and observing whether the sleep incidence rate of animals with the sub-threshold dose of the sodium pentobarbital can be improved by samples with different formulas of each administration group. As a result, as shown in table 11, it was found that the amount of the mice falling asleep was increased in each of the administration groups compared to the blank control group, and the group to which the sample # 1 prepared in the best number of administration parts was administered was the best in the effect of falling asleep.
TABLE 11 sleep volume of mice in each group
Group of | Dosage (g/kg/day) | Number of animals sleeping (one) | Ratio of sleeping animals (%) |
Blank control group | 0 | 1 | 10 |
Positive control group | 10 | 2 | 20 |
Sample No. 1 group | 10 | 7 | 70 |
Sample No. 2 group | 10 | 5 | 50 |
Sample No. 3 group | 10 | 4 | 40 |
Sample No. 4 group | 10 | 3 | 30 |
Sample No. 5 group | 10 | 3 | 30 |
Sample No. 6 group | 10 | 4 | 40 |
Sample 7# group | 10 | 1 | 10 |
Sample No. 8 group | 10 | 3 | 30 |
Sample No. 9 group | 10 | 2 | 20 |
Sample No. 10 group | 10 | 2 | 20 |
Sample No. 11 group | 10 | 3 | 30 |
Sample No. 12 group | 10 | 2 | 20 |
Sample No. 13 group | 10 | 3 | 30 |
Sample No. 14 group | 10 | 4 | 40 |
Sample No. 15 group | 10 | 3 | 30 |
Comparative sample No. 1 group | 10 | 3 | 30 |
(5) Influence of traditional Chinese medicine composition and sleep-aiding traditional Chinese medicine tea on sleep latency of sodium pentobarbital
After 15min of the last administration, 240mg/kg of sodium pentobarbital is injected into the abdominal cavity of each group of mice, and the injection amount is 0.1ml/10 g. The sleep latencies of the groups with different dosages and the blank control group are recorded, and the difference of the sleep latencies of different groups is compared, so that the sleep latency of each administration group can be obviously shortened (P is less than 0.01) compared with that of the blank control group, and the sleep latency of the sample No. 1 group is the shortest. The results are shown in Table 12.
TABLE 12 sleep latency in groups of mice
Group of | Dosage (g/kg/d) | Sleep latency (min) |
Blank control group | 0 | 18.58±0.84 |
Positive control group | 10 | 17.36±0.94* |
Sample No. 1 group | 10 | 13.36±0.92**## |
Sample No. 2 group | 10 | 14.04±0.86**## |
Sample No. 3 group | 10 | 14.53±0.88**## |
Sample No. 4 group | 10 | 15.35±0.97**## |
Sample No. 5 group | 10 | 15.30±0.95**## |
Sample No. 6 group | 10 | 14.61±0.91**## |
Sample 7# group | 10 | 17.25±0.69* |
Sample No. 8 group | 10 | 16.24±0.93**# |
Sample No. 9 group | 10 | 17.07±0.79* |
Sample No. 10 group | 10 | 16.21±0.84**# |
Sample No. 11 group | 10 | 15.51±0.82**## |
Sample No. 12 group | 10 | 16.01±0.88**# |
Sample No. 13 group | 10 | 15.95±0.97**# |
Sample No. 14 group | 10 | 15.25±0.94**## |
Sample No. 15 group | 10 | 15.87±0.89**# |
Comparative sample No. 1 group | 10 | 16.24±0.88**# |
Note: "+" indicates experimental groups compared to blank control groups,. + -. P <0.05,. + -. P < 0.01; "#" indicates that # P <0.05 and # P <0.01 in the experimental group compared with the positive group.
According to experimental results, the traditional Chinese medicine composition prepared by the application can obviously improve the hair color of a tested mouse, so that the tested mouse is smoother and glossy, has no adverse effect on the weight of the tested mouse, and has no direct sleeping effect on the mouse. Can prolong the sleep time induced by the sodium pentobarbital, increase the sub-threshold dose of the sodium pentobarbital to induce the sleep rate of animals, and shorten the sleep latency period of the sodium pentobarbital to induce the animals to sleep. The effect of the comparative sample No. 1 is inferior to that of the samples No. 1 to No. 15, and the effects of the samples No. 4, No. 5, No. 7, No. 8, No. 9, No. 10, No. 11, No. 12, No. 13, No. 14 and No. 15 without donkey-hide gelatin are slightly inferior to those of the other samples, and the effect of the commercial sleep-aiding herbal tea is less significant than that of the samples No. 1 to No. 15.
The embodiments in the present specification are described in a progressive manner, and the same and similar parts among the embodiments are referred to each other, and each embodiment focuses on the differences from the other embodiments. In particular, for the system embodiment, since it is substantially similar to the method embodiment, the description is simple, and for the relevant points, reference may be made to the partial description of the method embodiment.
The above description is only an example of the present application and is not intended to limit the present application. Various modifications and changes may occur to those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.
Claims (4)
1. The traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young is characterized by comprising the following raw materials in parts by weight: 5-15 parts of astragalus membranaceus, 20-30 parts of cistanche, 2-10 parts of fructus amomi, 30-40 parts of liquorice, 7-17 parts of raspberry, 7-17 parts of wolfberry, 20-30 parts of Chinese yam, 5-15 parts of poria cocos, 140-160 parts of chicken embryo, 2-10 parts of ginseng, 2-10 parts of cinnamon, 7-17 parts of honeysuckle, 25-35 parts of mulberry, 10-20 parts of hawthorn and 2-8 parts of donkey-hide gelatin;
the preparation method of the traditional Chinese medicine composition comprises the following steps:
1) crushing ginseng into powder and donkey-hide gelatin into blocks for later use; the fineness of the ginseng powder is 80-120 meshes, and the fineness of the donkey-hide gelatin blocks is 3-7 meshes;
2) decocting 13 medicinal materials including astragalus, cistanche, fructus amomi, liquorice, raspberry, wolfberry fruit, Chinese yam, poria cocos, chicken embryo, cinnamon, honeysuckle, mulberry and hawthorn in water for 2-3 times, 1-2 hours each time, filtering for 2-3 times, merging filtrate, and concentrating the filtrate at 85-95 ℃ until the relative density is 1.05-1.10 to obtain final filtrate;
3) adding the ginseng powder and the donkey-hide gelatin blocks prepared in the step 1) into the final filtrate obtained in the step 2), uniformly mixing, continuously concentrating the filtrate at 85-95 ℃ until the relative density is 1.25-1.35, adding 240-260 parts of malt syrup according to parts by weight, uniformly mixing, and filling.
2. The use of the Chinese medicinal composition for benefiting qi, nourishing blood, and caring skin according to claim 1, wherein the Chinese medicinal composition is prepared into soft extract, tablet, capsule, oral solution, granule, paste, powder, and emulsion.
3. The use of the Chinese medicinal composition for benefiting qi, nourishing blood, and caring skin of claim 1, wherein the Chinese medicinal composition is prepared into nutritional supplement and functional food.
4. The traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young is characterized by comprising the following raw materials in parts by weight: 5-15 parts of astragalus membranaceus, 20-30 parts of cistanche, 2-10 parts of fructus amomi, 30-40 parts of liquorice, 7-17 parts of raspberry, 7-17 parts of wolfberry, 20-30 parts of Chinese yam, 5-15 parts of poria cocos, 140-160 parts of chicken embryo, 2-10 parts of ginseng, 2-10 parts of cinnamon, 7-17 parts of honeysuckle, 25-35 parts of mulberry, 10-20 parts of hawthorn and 2-8 parts of donkey-hide gelatin;
the preparation method of the traditional Chinese medicine composition comprises the following steps:
1) mixing the plant medicinal materials uniformly, and crushing the mixture into plant medicinal material coarse powder by a crusher; pulverizing the animal medicinal material chicken embryo into animal medicinal material coarse powder by a pulverizer;
2) percolating and refining plant medicinal materials
2.1) adding 60-80% ethanol into the coarse powder of the plant medicinal material, stirring, fully infiltrating, moistening for 0.8-1.3 hours, filling into a percolation device, then adding 60-80% ethanol to submerge the medicinal material, wherein the amount of the ethanol is 3-6 times of that of the medicinal material, and percolating at a flow rate of one drop per second after soaking for 2-4 days;
2.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at the temperature of 75-85 ℃ to obtain a plant medicinal material concentrated solution;
2.3) placing the concentrated solution of the plant medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the plant medicinal materials;
2.4) filtering;
3) percolation and refining of animal medicinal materials
3.1) adding 60-80% ethanol into animal crude powder, stirring, fully infiltrating, moistening for 0.8-1.3 hours, loading into a percolation device, then adding 60-80% ethanol to submerge the crude powder, wherein the amount of the ethanol is 3-6 times of that of the crude powder, and percolating at a flow rate of one drop per second after soaking for 2-4 days;
3.2) collecting the percolate into a concentrator, recovering ethanol until no alcohol smell exists, and concentrating at 75-85 ℃ to obtain an animal medicinal material concentrated solution;
3.3) placing the concentrated solution of the animal medicinal materials into a cold precipitation tank, adding purified water while stirring, uniformly stirring, adding kaolin, fully and uniformly stirring, cooling the liquid to 1-4 ℃, preserving heat and standing for 16-20 hours to obtain refined solution of the animal medicinal materials;
3.4) filtering and clarifying, adding 1-3% of activated carbon, fully and uniformly stirring, boiling for 8-12 minutes, cooling to 45-50 ℃, and filtering and clarifying again;
4) mixing the animal medicine refined liquid and the plant medicine refined liquid, boiling for 8-12 minutes, cooling to 1-4 ℃, preserving heat, standing for 16-20 hours, filtering and clarifying to obtain a mixed refined liquid;
5) weighing a sweetening agent and potassium sorbate, preparing a 0.1-0.3% cardamom oil wine solution, adding purified water, the sweetening agent and the potassium sorbate into the mixed refined solution, stirring until the mixture is melted, then dripping the cardamom oil wine solution, stirring uniformly, and supplementing the purified water;
6) filtering the feed liquid obtained in the step 5), and refrigerating and storing filtrate;
7) and (6) filling and sterilizing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011111015.7A CN112107612B (en) | 2020-10-16 | 2020-10-16 | Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011111015.7A CN112107612B (en) | 2020-10-16 | 2020-10-16 | Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112107612A CN112107612A (en) | 2020-12-22 |
CN112107612B true CN112107612B (en) | 2022-04-12 |
Family
ID=73794303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011111015.7A Active CN112107612B (en) | 2020-10-16 | 2020-10-16 | Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112107612B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115715793B (en) * | 2021-08-25 | 2023-09-29 | 美敦宜(山东)健康食品有限公司 | Chicken embryo and rhizoma polygonati herbal paste and production method thereof |
CN116392527B (en) * | 2023-03-10 | 2024-02-13 | 山东宏济堂制药集团股份有限公司 | Preparation for improving chronic kidney disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102696808A (en) * | 2012-06-21 | 2012-10-03 | 济南仙汤姆生物技术有限公司 | Blood nourishing and facial beautifying composition and preparation method thereof |
-
2020
- 2020-10-16 CN CN202011111015.7A patent/CN112107612B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102696808A (en) * | 2012-06-21 | 2012-10-03 | 济南仙汤姆生物技术有限公司 | Blood nourishing and facial beautifying composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112107612A (en) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547534B (en) | A kind of herbal health care oral solution with efficacy of relieving visual fatigue | |
CN1170588A (en) | Pure natural plant human life energy nutritive substrate | |
CN104208302A (en) | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof | |
CN103041264B (en) | Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof | |
CN104398986A (en) | Tranquilization and brain tonifying epimedium herb oral liquid and preparation method thereof | |
CN112107612B (en) | Traditional Chinese medicine composition for benefiting qi, nourishing blood, maintaining beauty and keeping young as well as preparation method and application thereof | |
CN107952040A (en) | For nursing one's health the Chinese herbal ointment formula and its processing method of obstruction of the circulation of vital energy constitution | |
CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
CN105434857A (en) | Health-care finger citron oral solution for soothing liver, removing blood stasis and fading freckles as well as preparation method of oral solution | |
CN105614719A (en) | Colla corii asini cake for whitening and removing freckles and preparation method thereof | |
CN105495597A (en) | Donkey-hide gelatin cake having functions of resisting aging, maintaining beauty and keeping young and used for patients with diabetes as well as preparation method of donkey-hide gelatin cake | |
CN105495374A (en) | Skin-whitening and freckle-removing pig tripe medicated diet applicable to pregnant women and preparation method of medicated diet | |
CN113133957A (en) | Plant fermentation lifting compact anti-oxidation anti-fatigue eye mask and preparation method thereof | |
CN105125946A (en) | Gardenia oral liquid clearing away heart fire and relieving restlessness and preparing method thereof | |
CN105076617A (en) | Tartary buckwheat tea and preparation method thereof | |
CN104473153B (en) | A kind of Fructus Mori oral liquid of looks improving and the skin nourishing and preparation method thereof | |
CN103251802A (en) | Appearance paste and preparation method thereof | |
CN105410716A (en) | Pork tripe medicinal diet for whitening skin and removing spots and preparation method thereof | |
CN105614718A (en) | Hair blackening, beauty maintaining and young keeping medicinal food applicable to diabetes patients and preparation method of medicinal food | |
CN103830558B (en) | Anti-aging composition and preparation method thereof | |
CN105012873A (en) | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof | |
CN104783174A (en) | Preparation method of pure natural nutritional, immune and health solid beverage | |
CN104324329A (en) | Mulberry oral liquid with effects of soothing nerves and nourishing brain and preparation method of mulberry oral liquid | |
CN104397282A (en) | Tranquilization and brain tonifying eleutherococcus senticosus healthare tea and preparation method thereof | |
CN105614849A (en) | Valeriana officinalis and grape seed colla corii asini cake dedicated for pregnant women to maintain beauty and keep young, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |